Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer

903.5000 -1.20 (-0.13%)

NSE May 16, 2025 10:21 AM

31.78% Fall from 52W High

Volume: 139.0K

Zydus Lifesciences Ltd.

07 Nov 2022

903.50

-0.13%

Company Update

Zydus Lifesciences Ltd - 532321 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Zydus receives EIR with Voluntary Action Indicated (VAI) from USFDA for its Moraiya manufacturing facility

More from Zydus Lifesciences Ltd.

All Rapid Results

Recommended

Market opens flat, JSW Energy's net profit surges 16.1% YoY to Rs 408.1 crore in Q4

Trendlyne Marketwatch | 16 May 2025, 10:02AM

A car running on flat tires: Pakistan's economy is struggling

The Baseline | 15 May 2025, 09:48AM

Earnings Call Transcript - Cadila Healthcare

| 14 Feb 2020, 01:51PM